Understanding the Landscape of Specialty Pharmacy From the Viewpoint of Many Stakeholders:
Manufacturer, Payor, Consultant, Hub
Moderator:
Philip P. Gerbino, Pharm.D.
President Emeritus, University of the Sciences
Linwood F. Tice Professor
Philadelphia College of Pharmacy
Panelists:
Michael Castagna, PharmD
Executive Director, Immunoscience
Bristol Myers Squibb

Saira A. Jan, MS, PharmD
Director of Clinical Pharmacy Management
Horizon Blue Cross Blue Shield of New Jersey
Clinical Professor
Rutgers State University of New Jersey


Heather Morel
Vice President & General Manager
Reimbursement, Access & Safety Services|AccessMED
McKesson Specialty Health

David M Suchanek
Senior Vice President, Biotech and Specialty Services
D2 Pharma Consulting
Presentation Overview

The specialty pharmacy market has seen tremendous growth of the last 5 years. This growth is due to a number of reasons including the approval of new specialty medications, approval of indications for existing products, and an increase in the number of patients diagnosed and seeking treatment with these types of medications. This panel discussion will include key stakeholders involved with manufacturing, distribution, dispensing, and reimbursement of specialty pharmaceuticals.Panelists will discuss the roles and responsibilities of each stakeholder, issues that are driving the marketplace, how various stakeholders work together to influence and improve patient care, and the operational needs to successfully providespecialty pharmacy services. There will be discussions on issues specific to providing specialty pharmacy stakeholder including limited distribution and participation in the RFP process, the implications of REMS , the role of physicians in specialty pharmacy, and identification of potential trends that may affect the market.

Presentation Objectives To submit a question to the panel please fill out the form below.
Questions will be screened due to the limited time for the panel discussion.
Name:
Email:
Question: